Abstract
The global market for glucose testing products is undergoing a significant
transition driven by the advent of new analytical technologies and
developments in diabetes treatment. Although the glucose testing segment of
the in vitro diagnostics (IVD) industry is mature, certain segments of the
market such as home testing devices for diabetes management will exhibit
strong growth, with some-such as non-invasive testing-representing major new
areas of application for IVD testing. Direct access testing, or
over-the-counter, which allows consumers to order tests themselves without
visiting a doctor, has emerged as a strong force in the glucose-testing
segment. Moreover, an increasing range of test devices is now available to
consumers for use in self-testing. The purpose of this TriMark Publications
report is to describe the specific market segments for blood glucose testing
and diabetes management. This study reviews all of the generally-accepted
clinical analytical methods that are currently in use today for measuring
serum or plasma or whole-blood glucose concentrations. Moreover, it examines
clinical measurement devices, reagents and supplies as utilized in hospitals,
clinics, doctors' offices and at-home care locations.
View Cart
